Objectives The primary aim of this non-inferiority study was to investigate the clinical
effectiveness and safety of generic escitalopram (Lexacure®) versus branded escitalopram …

Background Escitalopram is licensed for use at doses up to 20 mg but is used clinically at
higher doses. There is limited published data at higher doses and none in the treatment of …

Escitalopram (escitalopram oxalate; Cipralex®, Lexapro®), a selective serotonin reuptake
inhibitor (SSRI) indicated for the treatment of major depressive disorder (MDD) …

Abstract Escitalopram (Cipralex®, Lexapro™), the active S-enantiomer of the racemic SSRI
citalopram (RS-citalopram), is a highly selective inhibitor of the serotonin transporter protein …

Objective: To assess the relative antidepressant efficacy of escitalopram and comparator
antidepressants. Research design and methods: A meta-analysis was performed using …

Escitalopram (escitalopram oxalate; Cipralex®, Lexapro®) is a selective serotonin reuptake
inhibitor (SSRI) used for the treatment of major depressive disorder (MDD) and anxiety …

Background: Escitalopram is an allosteric selective serotonin reuptake inhibitor (SSRI) with
some indication of superior efficacy in the treatment of major depressive disorder. In this …

Efficacy of escitalopram monotherapy in the treatment of maj... : Medicine Efficacy of
escitalopram monotherapy in the treatment of major depressive disorder: A pooled analysis …

The aim of the study was to conduct a multicenter randomized double-blinded placebo-
controlled clinical study to evaluate the efficacy of a generic form of escitalopram in treating …

Post-hoc pooled analysis of data from two 6-month randomised controlled trials in patients
with major depressive disorder (MDD) revealed superior efficacy and tolerability of …